590 related articles for article (PubMed ID: 16569855)
21. Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model.
Griffith DC; Rodriguez D; Corcoran E; Dudley MN
Antimicrob Agents Chemother; 2008 Jan; 52(1):244-7. PubMed ID: 17954697
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.
Lepak AJ; Parhi A; Madison M; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6568-74. PubMed ID: 26259789
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
24. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus.
Lepak AJ; Zhao M; Andes DR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551
[TBL] [Abstract][Full Text] [Related]
25. Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection model.
Dandekar PK; Tessier PR; Williams P; Zhang C; Nightingale CH; Nicolau DP
Chemotherapy; 2004 Apr; 50(1):11-6. PubMed ID: 15084799
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
[TBL] [Abstract][Full Text] [Related]
27. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
Crandon JL; Banevicius MA; Nicolau DP
Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
[TBL] [Abstract][Full Text] [Related]
29. In vivo pharmacodynamic activity of daptomycin.
Safdar N; Andes D; Craig WA
Antimicrob Agents Chemother; 2004 Jan; 48(1):63-8. PubMed ID: 14693519
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
33.
Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
[TBL] [Abstract][Full Text] [Related]
34.
Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416552
[TBL] [Abstract][Full Text] [Related]
35. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Biek D; Critchley IA; Riccobene TA; Thye DA
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
[TBL] [Abstract][Full Text] [Related]
36. In vivo pharmacodynamics of new lipopeptide MX-2401.
Craig WA; Andes DR; Stamstad T
Antimicrob Agents Chemother; 2010 Dec; 54(12):5092-8. PubMed ID: 20855736
[TBL] [Abstract][Full Text] [Related]
37. In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Sugihara K; Sugihara C; Matsushita Y; Yamamura N; Uemori M; Tokumitsu A; Inoue H; Kakuta M; Namba E; Nasu H; Koga T
Antimicrob Agents Chemother; 2010 Dec; 54(12):5298-302. PubMed ID: 20921311
[TBL] [Abstract][Full Text] [Related]
38. Investigation on rifampicin administration from the standpoint of pharmacokinetics/pharmacodynamics in a neutropenic murine thigh infection model.
Hirai J; Hagihara M; Kato H; Sakanashi D; Nishiyama N; Koizumi Y; Yamagishi Y; Suematsu H; Hanaki H; Mikamo H
J Infect Chemother; 2016 Jun; 22(6):387-94. PubMed ID: 27029221
[TBL] [Abstract][Full Text] [Related]
39. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Lepak AJ; Marchillo K; Pichereau S; Craig WA; Andes DR
Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
[TBL] [Abstract][Full Text] [Related]
40. Eravacycline (TP-434) is efficacious in animal models of infection.
Grossman TH; Murphy TM; Slee AM; Lofland D; Sutcliffe JA
Antimicrob Agents Chemother; 2015 May; 59(5):2567-71. PubMed ID: 25691636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]